Abstract:OBJECTIVE:To develop a new kind of vector system called gene-viral vector, which combines the advantages of gene and virus therapies.METHODS:Using recombinant technology, an anti-tumor gene was inserted into the genome of replicative virus specific for tumor cells. The cell killing effect, reporter gene expression of the green fluorescence protein, anti-tumor gene expression of mouse interleukin-12 (mIL-12) and replication of virus were observed by the methods of cell pathology, fluorescence microscopy, ELISA and electron microscopy, respectively.RESULTS:A new kind of gene-viral vector system of adenovirus, in which the E1b-55 kD gene was deleted but the E1a gene was preserved, was constructed. The vector system, like the replicative virus ONYX-015, replicated and proliferated in tumor cells but not in normal ones. Our vector had an advantage over ONYX-015 in that it carried different kinds of anti-tumor genes to enhance its therapeutic effect. The reporter gene expression of the green fluorescence protein in tumor cells was much better than the adenovirus vector employed in conventional gene the rapy, and the expression in our vector system was as low as or even less than that in the conventional adenovirus gene therapy system. Similar results were observed in experiments with this vector system carrying the anti-tumor gene mIL-12. Replication and proliferation of the virus carrying the mIL-12 gene in tumor cells were confirmed by electron microscopy.CONCLUSIONS:Gene-viral vectors are new vectors with an anti-tumor gene inserted into the genome of replicative virus specific for tumor cells. Because of the specific replication and proliferation of the virus in tumor cells, expression of the anti-tumor gene is increased hundreds to thousands of times. This approach takes full advantages of gene therapy and virus therapy to enhance the effect on the tumor. It overcomes the disadvantages of conventional gene therapy, such as low transfer rate, low gene expression, lack of target tropism, and low anti-tumor activity. We believe that this is a promising means for future tumor treatment.

Original Article A fiber-modified adenovirus co-expressing HSV-TK and Coli.NTR enhances antitumor activities in breast cancer cells

A Fiber-Modified Adenovirus Co-Expressing HSV-TK and Coli.NTR Enhances Antitumor Activities in Breast Cancer Cells.

Co-expression of Herpes Simplex Virus Thymidine Kinase and Escherichia Coli Nitroreductase by an Htert-Driven Adenovirus Vector in Breast Cancer Cells Results in Additive Anti-Tumor Effects.

Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation.

Mutation in fiber of adenovirus serotype 5 gene therapy vector decreases liver tropism.

A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy

Utilizing Adenovirus Knob Proteins as Carriers in Cancer Gene Therapy Amidst the Presence of Anti-Knob Antibodies

Fiber-modified Adenoviral Vector Expressing the Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Gene from the Human Telomerase Reverse Transcriptase Promoter Induces Apoptosis in Human Hepatocellular Carcinoma Cells

[Gene Expression of Tumor Cells Both in Vitro and in Vivo Enhanced by Integrin-Targeting Adenovirus Vector].

Potent Anti-Tumor Activity of Telomerase-Dependent and HSV-TK Armed Oncolytic Adenovirus for Non-Small Cell Lung Cancer in Vitro and in Vivo

Transient Chimeric Ad5/37 Fiber Enhances NK-92 Carrier Cell-Mediated Delivery of Oncolytic Adenovirus Type 5 to Tumor Cells

A Novel Oncolytic Adenovirus Expressing Escherichia Coli Cytosine Deaminase Exhibits Potent Antitumor Effect on Human Solid Tumors

A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route.

Gene-viral Vectors: a Promising Way to Target Tumor Cells and Express Anticancer Genes Simultaneously.

In vitro antitumor effect of CD, TK fusion suicide gene induced by adenovirus vector

5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells.

Tetracycline controlled DT/VEGF system gene therapy mediated by adenovirus vector

Fiber-modified Adenovirus-Mediated Suicide Gene Therapy Can Efficiently Eliminate Bladder Cancer Cells in Vitro and in Vivo

Anti-tumor Effect of Adenovirus-Mediated Suicide Gene Therapy under Control of Tumor-Specific and Radio-Inducible Chimeric Promoter in Combination with Γ-Ray Irradiation in Vivo

Engineered Adenovirus Fiber Shaft Fusion Homotrimer of Soluble Trail with Enhanced Stability and Antitumor Activity

Adenovirus with hexon Tat-protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors